Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome

Endocrine Journal

Volumn 50, Issue 1, 2003, Pages 1-7

  Ohmori, Nariko ^a   Nomura, Kaoru ^a   Ohmori, Kazue ^a   Kato, Yoshiharu ^a   Itoh, Tatsuo ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenal Cushing's syndrome; Bone mineral density; Osteoporosis; Pituitary Cushing's syndrome

Indexed keywords

17 OXOSTEROID; ANDROGEN; PRASTERONE SULFATE;

ADRENAL GLAND; ADULT; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MINERAL; BONE RADIOGRAPHY; CLINICAL ARTICLE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHING DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; HYPOPHYSIS; LUMBAR SPINE; MALE; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR;

ADRENOCORTICAL HYPERFUNCTION; ADULT; BONE DENSITY; CUSHING SYNDROME; FEMALE; HUMANS; HYPERPITUITARISM; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS;

EID: 0037296379     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.1     Document Type: Article

References (25)

1. Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophillism). Bulletin of Johns Hopkins Hospital 50: 137-195.
2. Grampp S, Steiner E, Imhof H (1997) Radiological diagnosis of osteoporosis. Eur Radiol 7 Suppl 2: S11-19.
3. Lukert BP (1996) Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds), Osteoporosis, Academic Press, San Diego 801-820.
4. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Pileri M, Modonis S, Di Giorge A, Liuzzi A, Minisola S, Cammisa M, Trischitta V, Scillitani A (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83: 1863-1867.
5. Sprague RG, Randall RV, Salassa RM, Scholz RV, Priestley JT, Walters W, Bulbulian AH (1956) Cushing's syndrome. A progressive and often fatal disease. Arch Intern Med 98: 389-396.
6. Ross EJ, Marshall-Jones P, Friedman M (1966) Cushing's syndrome: diagnostic criteria. Q J Med 35: 149-192.
7. Tomita A, Kawakubo A, Yoneda M, Oiso Y, Takatsuki K (1988) Osteoporosis and calcium metabolism in Cushing's syndrome. In: Takeda R, Miyamori I (eds) Controversies in Disorders of Adrenal Hormones, Elsevier Science Pub BV, Amsterdam 43-47.
8. Demura H (1991) Survey of Cushing's syndrome. Folia Endocrinol 67: 730-739. (In Japanese)
9. Carpenter PC (1988) Diagnostic evaluation of Cushing syndrome. Endocrinol Metab Clin North Am 17: 445-472.
10. Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 80: 2859-2865.
11. Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7: 1221-1225.
12. Japanese Society of Bone Mineral Research (2000) Diagnostic criteria for primary osteoporosis: 2000 edition. Osteoporosis Jpn. 18: 76-82 (in Japanease).
13. Khanine V, Fournier J-J, Requeda E, Luton J-P, Simon F, Crouzet J (2000) Osteoporotic fractures at presentation of Cushing's disease; two case reports and a literature review. Joint Bone Spine 67: 341-345.
14. Compston JE (1992) Risk factors for osteoporosis. Clin Endocrinol (Oxf). 36: 223-224.
15. Ribot C, Pouilles JM, Bonneu M, Tremollieres F (1992) Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol (Oxf). 36: 225-228.
16. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15: 993-1000.
17. Russell-Aulet M, Wang J, Thornton JC, Colt EW, Pierson RN Jr (1993) Bone mineral density and mass in a cross-sectional study of white and Asian women. J Bone Miner Res 8: 575-582.
18. Cundy T, Cornish J, Evans MC, Gamble G, Stapleton J, Reid IR (1994) Sources of interracial variation in bone mineral density. J Bone Miner Res 10: 368-373.
19. Davis JW, Novotny R, Ross PD, Wasnich RD (1994) The peak bone mass of Hawaiian, Filipino, Japanese, and white women living in Hawaii. Calcified Tissue Int 55: 249-252.
20. Gennari C, Imbimbo B (1985) Effects of prednisone and deflazacort on vertebral bone mass. Calcified Tissue Int 37: 592-593.
21. Formiga F, Moga I, Nolla JM, Navarro MA, Bonnin R, Roig-Escofet D (1997) The association of dehydroepiandrosterone sulfate levels with bone mineral density in systemic lupus erythematosus. Clin Exp Rheumatol 15: 387-392.
22. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82: 3498-3505.
23. Hay PJ, Delahunt JW, Hall A, Mitchell AW, Harper G, Salmond C (1992) Predictors of osteopenia in premenopausal women with anorexia nervosa. Calcif Tissue Int 50: 498-501.
24. Gennari C (1994) Glucocorticoid induced osteoporosis. Clin Endocrinol (Oxf). 41: 273-274.
25. Di Somma C, Colao A, Pivonello R, Klain M, Faggiano A, Tripodi FS, Merola B, Salvatore M, Lombardi G (1998) Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Clin Endocrinol (Oxf) 48: 655-662.